Product Images Otezla
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Otezla NDC 55513-485 by Amgen Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text describes a graph showing the mean number of oral ulcers over time (in weeks) for a placebo group and a group taking TEZLA 30 mg twice daily. It is not clear what type of study or condition is being investigated.*
This is a graph showing the mean oral ulcer pain of a certain medication (Otezla 30mg twice daily) compared to a placebo over the duration of several weeks. The pain is measured on a scale of 0 to 100.*
This is a medication package containing 98 tablets of Otezla (apremilast) manufactured by Amgen with a National Drug Code of 55513-137-28. The packaging features the brand name RcOnly and lists the cost per tablet, but no additional information is available.*
This text provides information regarding the medication Otezla (apremilast) tablets with the NDC code 55513-137-60. It also provides directions on how to store the tablets and recommends consulting full prescribing information for proper dosage and administration information. The text mentions that Otezla is a registered trademark of Amgen Inc. and the medication is manufactured in Switzerland. Finally, the text lists the patent for Otezla and provides copyright information for Amgen Inc.*
These are tablets of Apremilast, with NDC 55513-369-55, available in a Starter Pack. The pack contains four 10 mg tablets, four 20 mg tablets, and forty-seven 30 mg tablets, which should be gradually titrated over 5 days up to the prescribed dose of 30 mg. The manufacturer of these tablets is AMGEN®.*
This is a description for a starter pack of Otezla, a drug with the generic name Apremilast. This pack is not available for sale and is intended for titration purposes over a 5-day period to reach the prescribed dose of 30mg. The pack contains a total of 27 tablets, including 4 tablets of 10mg, 4 tablets of 20mg, and 19 tablets of 30mg. The NDC code for this drug is 55513-485-95.*
This is a starter pack for Otezla, manufactured by Amgen, identified by the National Drug Code (NDC) 55513-485-96. It is not available for sale as it is labeled as a sample. The pack includes a total of 27 tablets for titration over, including four 10mg tablets, four 20mg tablets, and nineteen 30mg tablets.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.